Cancer

Managing missed opportunities when most cancer symptoms are only weakly predictive

Jon D Emery MB BCh, FRACGP, DPhil

Advances in radiation therapy have resulted in more precise and effective treatments with fewer side effects

Dion F Forstner MB BS(Hons), FRANZCR · Mei Ling Yap MB BS, BSc(Med), FRANZCR

Advising patients with cancer about life expectancy must be tailored to their individual desire for information

Alison C Zucca BA(Hons), MMedSc · Rob W Sanson-Fisher BPsych(Hons), MPsych, PhD · Amy Waller BA(Hons), PhD · Mariko Carey DPsych(Health), BSc(Hons) · Alice Grady BPsych · Lisa Mackenzie BPsych(Hons), PhD

High-quality cancer care can be provided at rural centres by teleoncology models

Bryan A Chan BPharm(Hons), MB BS(Hons), FRACP · Sarah L Larkins MB BS, PhD, FRACGP · Rebecca Evans BSp · Kerrianne Watt PhD · Sabe Sabesan BM BS, FRACP, PhD

Metastatic lymphadenopathy as the primary provisional diagnosis in adults with cystic neck masses

Chris Wratten MB BS, BMedSci, FRANZCR · Sravan Anne · Minh Thi Tieu MB BS, BSc(Med), FRANZCR · Balasubramaniam Kumar MD, DNB, FRANZCR · Robert Eisenberg MB BS, FRACS

Attitudes to what men should be told before undergoing a PSA test were examined

Chris Degeling PhD, BVSc · Lucie Rychetnik PhD, MPH · Kristen Pickles MPH · Rae Thomas PhD · Jennifer A Doust BM BS, PhD, FRACGP · Robert A Gardiner MD, FRCS, FRACS · Paul Glasziou BM BS, PhD, FRACGP · Ainsley J Newson PhD, LLB(Hons), BSc(Hons) · Stacy M Carter PhD, MPH(Hons)

Despite ongoing progress in basic and preclinical cancer nanomedicine research, arguably the single most important challenge is clinical translation

Zdenka Kuncic FAIP, PhD, BSc(Hons)

How can we help our patients make sensible decisions?

Ian E Haines MB BS, FRACP, FAChPM

Implementation of precision medicine requires a multidisciplinary and systematic approach

Ingrid Winship MD, FRACP, FACD

Some high-burden areas of disease fall short in research efforts

Jacquelyne Lam MPharm, BSc · Sarah J Lord MB BS, MS, FRACGP · Kylie E Hunter BA(Human Movement)(Hons), BA(Indonesian) · R John Simes MB BS(Hons), MD, FRACP · Thuyen Vu BSc · Lisa M Askie PhD, MPH, BN

While vemurafenib induces ultraviolet A photosensitivity, it is important to consider alternative diagnoses when minimal response to therapy is attained

Rachael Anforth BMed · Giuliana Carlos MB BS · Noemi Eiris MB BS · Arthur Clements BSc(Med), MB BS, FRACP · Pablo Fernandez-Peñas MD, PhD, FACD

Clinical research embedded in cancer treatment centres improves both outcomes and cure rates at minimal cost

Catherine H Cole MB BS, FRACP, FRCPA

Australian research advances technique that may make prostate cancer screening less invasive and more accurate

Jeremy P Grummet MB BS, MS, FRACS · Richard O’Sullivan BSc, MB BS, FRANZCR

Diabetic ketoacidosis in patients with type 2 diabetes can indicate primary pancreatic disease

George Zhong MB BS(Hons), BSc(Hons) · Rosalba Cross FCICM, MB BS, BSc(Hons)

Ian Olver considers his time at Cancer Council Australia and suggests embracing cancer treatment, prevention and research provides a comprehensive cancer control experience

Ian N Olver MB BS, MD, PhD

The many benefits for rural doctors and patients suggest it is time for telehealth to be part of routine clinical practice

Sabe Sabesan BM BS, FRACP · Jenny Kelly BN, MPH, PhD

General practice needs to be the pivot in the national screening program

Oliver R Frank PhD, FRACGP, FACHI · Nigel P Stocks DipPH, MD, FRACGP

Investigating the spread of cancer by cancer type among Aboriginal and non-Aboriginal people in NSW

Alison Gibberd MStat · Rajah Supramaniam BSc, MPH(Hons) · Anthony Dillon PhD · Bruce K Armstrong DPhil, FRACP, FAFPHM · Dianne L O’Connell BMaths(Hons), PhD

The pressing matters now are maximising outcomes, recruiting to clinical trials and being able to afford these drugs

Georgina V Long PhD, MB BS, FRACP

A more flexible approach than that currently mandated by the PBS is recommended

Craig Gedye MB ChB, FRACP, PhD · Frances M Boyle MB BS, PhD, FRACP

Limited use of aggressive treatment, but late referrals to palliative care and high numbers dying in acute hospitals after lengthy stays

Jennifer Philip PhD, FAChPM, MMed · Peter Hudson PhD, BN(Hons), DipAppSc · Adam Bostanci PhD, MPhil, MSc · Annette Street BEd(Hons), PhD · Dell E Horey PhD, MMedSc(ClinEpidemiol), BAppSc · Sanchia Aranda PhD, MN · Rachel Zordan PhD, BSc(Psych), BSc(Health) · Bruce D Rumbold PhD, MA, MSc · Gaye Moore PhD, MPD, BN(Hons) · Vijaya Sundararajan MD, MPH, FACP

Peer review of multidisciplinary teams can improve cancer care, but needs fine-tuning

Neli S Slavova-Azmanova MD, PhD · Claire E Johnson PhD · Cameron Platell MB BS, PhD, FRACS · Sean Bydder MB ChB, MBA, FRANZCR · Christobel M Saunders MB BS, FRCS, FRACS

Advanced age should not be the major factor in considering a patient for curative radiotherapy

Richard C Khor BMedSc, MB BS, FRANZCR · Mathias Bressel BSc, MSc · Jo Tedesco MBIT · Keen Hun Tai MB BS, FRANZCR · David L Ball MB BS, MD, FRANZCR · Gillian M Duchesne MB ChB, MD, FRANZCR · Helen Farrugia BAppSc(HIM), GradDip(BIT) · Wai Kuan Yip PhD, GradDipAppStats · Farshad Foroudi MB BS, MPA, FRANZCR

There must be a balanced investment portfolio in cancer control

David C Currow MPH, PhD, FRACP · Sanchia Aranda PhD, RN, GAICD

The benefits of sentinel lymph node biopsy are unproven

Samuel S Zagarella MB BS(Hons), FACD · Michael Sladden MB ChB, MRCP, FACD · Catalin Popescu MD, PhD · Michael Bigby MD